Analysts Cut Price Targets For Praxis Precision After Trial Setback For Essential Tremor Candidate Praxis Precision Medicines' ulixacaltamide study for essential tremor faces setback as IDMC ...

The latest price target for Praxis Precision Medicine (NASDAQ:PRAX) was reported by Oppenheimer on June 2, 2025. The analyst firm set a price target for $97.00 expecting PRAX to rise to within 12 ...

Throughout the last three months, 4 analysts have evaluated Praxis Precision Medicine (NASDAQ:PRAX), offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a ...

Across the recent three months, 8 analysts have shared their insights on Praxis Precision Medicine (NASDAQ:PRAX), expressing a variety of opinions spanning from bullish to bearish. The following ...

Precision medicine tailors healthcare to an individual’s genes, environment, and lifestyle, moving beyond a one-size-fits-all approach. Health insurance coverage significantly impacts access to ...

So, for this article, I’ve researched three of the best precision medicine stocks for investors to add to their portfolios. As we see a surge of interest in the industry, it is expected to grow ...

The Chicago-based company, which provides data and analytics tools for precision medicine, is looking to raise as much as $410.7 million by selling 11.1 million shares at a price range of $35 to $ ...